These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20390236)

  • 21. Refinement, reduction, and replacement of animal use for regulatory testing: future improvements and implementation within the regulatory framework.
    Richmond J
    ILAR J; 2002; 43 Suppl():S63-8. PubMed ID: 12388854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing.
    Basketter DA; Clewell H; Kimber I; Rossi A; Blaauboer B; Burrier R; Daneshian M; Eskes C; Goldberg A; Hasiwa N; Hoffmann S; Jaworska J; Knudsen TB; Landsiedel R; Leist M; Locke P; Maxwell G; McKim J; McVey EA; Ouédraogo G; Patlewicz G; Pelkonen O; Roggen E; Rovida C; Ruhdel I; Schwarz M; Schepky A; Schoeters G; Skinner N; Trentz K; Turner M; Vanparys P; Yager J; Zurlo J; Hartung T
    ALTEX; 2012; 29(1):3-91. PubMed ID: 22307314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From 3Rs to 3D: In vitro alternative models for replacement.
    Nagy AL; Catoi C; Socaciu C; Pintea A; Oros NA; Coman C; Rugina D; Matea CT; Mocan T; Coccini T; De Simone U; De Angelis I; Bertero A; Sambuy Y; Caloni F
    ALTEX; 2018; 35(3):420-421. PubMed ID: 30008010
    [No Abstract]   [Full Text] [Related]  

  • 24. Introduction to the EU REACH legislation.
    Grindon C; Combes R
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():1-6. PubMed ID: 19025328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for animal care committees and animal use oversight.
    Richmond J; Fletch A; Van Tongerloo R
    ILAR J; 2002; 43 Suppl():S129-32. PubMed ID: 12388867
    [No Abstract]   [Full Text] [Related]  

  • 26. Toxicity testing: the need for new maps for the future.
    Balls M
    Altern Lab Anim; 2011 Oct; 39(5):417-8. PubMed ID: 22103936
    [No Abstract]   [Full Text] [Related]  

  • 27. The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for biological: safety and potency evaluations.
    Cussler K; Kulpa J; Calver J
    ILAR J; 2002; 43 Suppl():S126-8. PubMed ID: 12388866
    [No Abstract]   [Full Text] [Related]  

  • 28. Introduction to the EU REACH legislation.
    Grindon C; Combes R
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():5-10. PubMed ID: 16555955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Race is on to find alternative to animal tests.
    Goodman S
    Nature; 2002 Jul; 418(6894):116. PubMed ID: 12110854
    [No Abstract]   [Full Text] [Related]  

  • 30. Ecotoxicity testing: science, politics and ethics.
    Walker CH
    Altern Lab Anim; 2008 Feb; 36(1):103-12. PubMed ID: 18333718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternatives to the use of animals in safety testing as required by the EU-Cosmetics Directive 2009.
    Vogel R
    ALTEX; 2009; 26(3):223-6. PubMed ID: 19907908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative in vitro methods to characterize the role of Endocrine Active Substances (EASs) in hormone-targeted tissues.
    Rovida C; De Angelis I; Lorenzetti S
    ALTEX; 2013; 30(2):253-5. PubMed ID: 23665809
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of animals for toxicology testing is necessary to ensure patient safety in pharmaceutical development.
    Mangipudy R; Burkhardt J; Kadambi VJ
    Regul Toxicol Pharmacol; 2014 Nov; 70(2):439-41. PubMed ID: 25058855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aligning the 3Rs with new paradigms in the safety assessment of chemicals.
    Burden N; Mahony C; Müller BP; Terry C; Westmoreland C; Kimber I
    Toxicology; 2015 Apr; 330():62-6. PubMed ID: 25932488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Food for thought ... on alternative methods for cosmetics safety testing.
    Hartung T
    ALTEX; 2008; 25(3):147-62. PubMed ID: 18841313
    [No Abstract]   [Full Text] [Related]  

  • 37. The patchwork of toxicological research for pharmaceutical testing.
    von Aulock S
    ALTEX; 2010; 27(1):1. PubMed ID: 20397314
    [No Abstract]   [Full Text] [Related]  

  • 38. Crucial data on REACH not disclosed.
    Gilbert N
    Nature; 2010 Apr; 464(7292):1116-7. PubMed ID: 20414283
    [No Abstract]   [Full Text] [Related]  

  • 39. Is there a need in regulatory toxicity testing for evaluating chemicals at doses eliciting general toxicity?
    Chahoud I; Grote K
    Toxicology; 2016 Jul; 363-364():46-7. PubMed ID: 27430607
    [No Abstract]   [Full Text] [Related]  

  • 40. Special anniversary volume - issue 6: replacement - focus on the testing of chemicals and products. Preface.
    Balls M
    Altern Lab Anim; 2009 Dec; 37(6):593-4. PubMed ID: 20301829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.